ROYAL BANK OF CANADA - ATYR PHARMA INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q3 2023$128,000
-29.7%
80,973
-4.1%
0.00%
Q2 2023$182,000
+13.0%
84,429
+9.5%
0.00%
Q1 2023$161,000
+2.5%
77,073
+7.4%
0.00%
Q4 2022$157,000
+6.8%
71,768
+47.3%
0.00%
Q3 2022$147,000
+14600.0%
48,727
+8857.2%
0.00%
Q2 2022$1,000
-85.7%
544
-59.2%
0.00%
Q1 2022$7,000
+75.0%
1,334
+166.8%
0.00%
Q4 2021$4,000500
+49900.0%
0.00%
Q2 2021$010.0%0.00%
Q4 2019$010.00%
Other shareholders
ATYR PHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,626,624$7,310,0662.43%
Tikvah Management LLC 2,460,833$3,888,1161.40%
TANG CAPITAL MANAGEMENT LLC 471,134$744,3920.10%
FEDERATED HERMES, INC. 10,169,600$16,067,9680.04%
Alyeska Investment Group, L.P. 2,455,555$3,879,7770.03%
XTX Topco Ltd 73,894$116,7530.02%
ALTERNA WEALTH MANAGEMENT, INC 10,000$15,8000.02%
Pale Fire Capital SE 55,857$88,2540.01%
GSA CAPITAL PARTNERS LLP 27,559$440.00%
Virtu Financial LLC 13,662$220.00%
View complete list of ATYR PHARMA INC shareholders